SK92496A3 - Endothelin receptor antagonists - Google Patents
Endothelin receptor antagonists Download PDFInfo
- Publication number
- SK92496A3 SK92496A3 SK924-96A SK92496A SK92496A3 SK 92496 A3 SK92496 A3 SK 92496A3 SK 92496 A SK92496 A SK 92496A SK 92496 A3 SK92496 A3 SK 92496A3
- Authority
- SK
- Slovakia
- Prior art keywords
- phenyl
- methoxyphenyl
- carboxymethyloxy
- dimethoxyphenyl
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19527568A DE19527568A1 (de) | 1995-07-28 | 1995-07-28 | Endothelin-Rezeptor-Antagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
SK92496A3 true SK92496A3 (en) | 1997-07-09 |
Family
ID=7767990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK924-96A SK92496A3 (en) | 1995-07-28 | 1996-07-16 | Endothelin receptor antagonists |
Country Status (16)
Country | Link |
---|---|
US (1) | US5700807A (es) |
EP (1) | EP0755934A1 (es) |
JP (1) | JPH0940678A (es) |
KR (1) | KR970006305A (es) |
AU (1) | AU6060796A (es) |
BR (1) | BR9603164A (es) |
CA (1) | CA2182156A1 (es) |
CZ (1) | CZ219796A3 (es) |
DE (1) | DE19527568A1 (es) |
HU (1) | HUP9602054A3 (es) |
MX (1) | MX9603045A (es) |
NO (1) | NO963131L (es) |
PL (1) | PL315422A1 (es) |
SK (1) | SK92496A3 (es) |
TW (1) | TW367328B (es) |
ZA (1) | ZA966399B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291442B1 (en) | 1998-02-03 | 2001-09-18 | The General Hospital Corporation | Pharmacological modulators of voltage-gated potassium ion channels |
IL125659A (en) † | 1998-08-05 | 2002-09-12 | Cadent Ltd | Method and device for three-dimensional simulation of a structure |
US6638929B2 (en) | 1999-12-29 | 2003-10-28 | Wyeth | Tricyclic protein kinase inhibitors |
DE10155076A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen |
AU2002351412B2 (en) | 2001-12-21 | 2010-05-20 | Exelixis Patent Company Llc | Modulators of LXR |
US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
CN1639146A (zh) * | 2002-02-22 | 2005-07-13 | 拜尔药品公司 | 用于治疗过度增生疾病的稠合三环杂环 |
EP1661881B1 (en) * | 2003-08-29 | 2014-12-17 | Ono Pharmaceutical Co., Ltd. | Compound capable of binding s1p receptor and pharmaceutical use thereof |
WO2015088564A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985422A (en) * | 1988-04-27 | 1991-01-15 | Glaxo Group Limited | Lactam derivatives |
RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
JP2667294B2 (ja) | 1991-11-05 | 1997-10-27 | スミスクライン・ビーチャム・コーポレイション | エンドセリン受容体拮抗剤 |
ZA939516B (en) | 1992-12-22 | 1994-06-06 | Smithkline Beecham Corp | Endothelin receptor antagonists |
ATE189217T1 (de) | 1993-03-19 | 2000-02-15 | Merck & Co Inc | Phenoxyphenylessigsäurederivate |
WO1995033748A1 (en) * | 1994-06-09 | 1995-12-14 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
-
1995
- 1995-07-28 DE DE19527568A patent/DE19527568A1/de not_active Withdrawn
-
1996
- 1996-07-12 TW TW085108491A patent/TW367328B/zh active
- 1996-07-16 SK SK924-96A patent/SK92496A3/sk unknown
- 1996-07-19 AU AU60607/96A patent/AU6060796A/en not_active Abandoned
- 1996-07-19 EP EP96111677A patent/EP0755934A1/en not_active Withdrawn
- 1996-07-25 CZ CZ962197A patent/CZ219796A3/cs unknown
- 1996-07-26 PL PL96315422A patent/PL315422A1/xx unknown
- 1996-07-26 JP JP8214052A patent/JPH0940678A/ja active Pending
- 1996-07-26 MX MX9603045A patent/MX9603045A/es unknown
- 1996-07-26 KR KR1019960030674A patent/KR970006305A/ko not_active Application Discontinuation
- 1996-07-26 NO NO963131A patent/NO963131L/no unknown
- 1996-07-26 ZA ZA9606399A patent/ZA966399B/xx unknown
- 1996-07-26 HU HU9602054A patent/HUP9602054A3/hu unknown
- 1996-07-26 CA CA002182156A patent/CA2182156A1/en not_active Abandoned
- 1996-07-26 US US08/687,922 patent/US5700807A/en not_active Expired - Fee Related
- 1996-07-26 BR BR9603164A patent/BR9603164A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9603164A (pt) | 1998-05-05 |
JPH0940678A (ja) | 1997-02-10 |
NO963131L (no) | 1997-01-29 |
NO963131D0 (no) | 1996-07-26 |
CZ219796A3 (en) | 1997-02-12 |
ZA966399B (en) | 1997-02-19 |
PL315422A1 (en) | 1997-02-03 |
KR970006305A (ko) | 1997-02-19 |
AU6060796A (en) | 1997-02-06 |
HUP9602054A3 (en) | 1998-07-28 |
MX9603045A (es) | 1997-01-31 |
CA2182156A1 (en) | 1997-01-29 |
TW367328B (en) | 1999-08-21 |
HU9602054D0 (en) | 1996-09-30 |
US5700807A (en) | 1997-12-23 |
DE19527568A1 (de) | 1997-01-30 |
EP0755934A1 (en) | 1997-01-29 |
HUP9602054A2 (en) | 1997-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100424045B1 (ko) | 엔도델린수용체길항제 | |
WO1998006722A1 (de) | Thienopyrimidine | |
SK280879B6 (sk) | Tetracyklické deriváty, spôsob ich výroby, ich použitie a farmaceutické prostriedky s ich obsahom | |
WO1997019077A1 (de) | Endothelin-rezeptor-antagonisten | |
CA2130859A1 (en) | Thienopyrimidine derivatives, their production and use | |
SK92496A3 (en) | Endothelin receptor antagonists | |
RU2138482C1 (ru) | Производные аминостильбазола или их гидраты, или их соли и фармацевтическая композиция на их основе | |
NO823026L (no) | 2(1h)-pyridinoner og fremgangsmaate for deres fremstilling | |
NO179411B (no) | Fremgangsmåte for fremstilling av pyrido[2,3-fÅ[1,4Åtiazepiner og pyrido[3,2-bÅ[1,5Åbenzotiazepiner | |
US4239887A (en) | Pyridothienotriazines | |
AU705959B2 (en) | Endothelin receptor antagonists | |
HU194238B (en) | Process for preparing ortho-condensed pyrrole derivatives and pharmaceuticals comprising the same | |
JPH10511118A (ja) | エンドテリン受容体拮抗薬 | |
JP2004504316A (ja) | 新規6−ヘテロアリールフェナンスリジン | |
NZ227441A (en) | Phthalazine derivatives and pharmaceutical compounds | |
US4524070A (en) | Aminated derivatives of pyridazine substituted in 6 position by a heterocycle or an alicycle and compositions, said derivatives being active on the central nervous system | |
JP2969911B2 (ja) | チオフェン化合物、その医薬用途およびその合成中間体 | |
DE19711785A1 (de) | Endothelin-Rezeptor-Antagonisten | |
CA2183307A1 (en) | Endothelin receptor antagonists | |
FI77033C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,6-naftyridin-2(1h)-onderivat. | |
EP1599473B1 (en) | Imidazo 4,5-b quinoline-derivatives and their use as no-synthase inhibitors | |
MXPA97004262A (es) | Piridazinonas como antagonistas del receptor endotelial | |
SU1340587A3 (ru) | Способ получени производных конденсированных бензопиронов или их фармацевтически приемлемых солей | |
US4604399A (en) | 5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their preparation and the cardiotonic use thereof | |
JPH08277266A (ja) | スピロ三環式芳香族スクシンイミド誘導体、並びにヒト及び動物の糖尿病合併症治療剤 |